Latest Period
Q2 2026
Security Snapshot
Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA) Institutional Ownership
CUSIP: 92337R101
13F Institutional Holders and Ownership History from Q2 2021 to Q2 2026
Institutions Reporting
218
Shares (Excl. Options)
77,932,315
Price
$42.91
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A common stock, $0.001 par value per share
- Symbol
- VERA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 77,932,315
- Total 13F value
- $3,340,046,613
- Portfolio coverage rank
- 0.01%
- Share change
- +5,972,716
- Value change
- +$264,642,531
- Number of holders
- 218
- Shares outstanding
- 71,530,793
- SEC-reported price per share
- $28.89
- Insider filing price
- $28.89
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- VERA - Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share is tracked under CUSIP 92337R101.
- 218 institutions reported positions in Q2 2026.
- 10 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 227 to 218 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,918,504,604 to $3,340,046,613.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 218 institutions filings for Q2 2026.
Security key
92337R101
Latest holder period
Q2 2026
13F holders
218
13D/G owners
10
CIK / CUSIP context first
Open Q2 2026 holders
VERA full holder history
Vera Therapeutics, Inc. SEC filings
Vera Therapeutics, Inc. company facts
Vera Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 92337R101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
10
Security
VERA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 8.9% | $134,640,000 | 5,610,000 | Avoro Capital Advisors LLC | 31 Dec 2024 | |||
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.7% | +33% | $276,595,072 | +$90,918,550 | 5,461,988 | +49% | T. Rowe Price Associates, Inc. | 31 Dec 2025 |
| BlackRock, Inc. | 7.4% | $229,161,799 | 5,340,522 | BlackRock, Inc. | 30 Jun 2026 | |||
| STATE STREET CORP | 5.8% | $172,174,619 | 4,148,786 | STATE STREET CORPORATION | 30 Jun 2026 | |||
| Deep Track Capital, LP | 5.5% | $176,892,640 | 3,921,362 | Deep Track Capital, LP | 04 Mar 2026 | |||
| VANGUARD GROUP INC | 5% | $180,805,107 | 3,570,401 | The Vanguard Group | 31 Dec 2025 | |||
| Flynn James E | 5.2% | $75,299,151 | 3,348,117 | Deerfield Mgmt, L.P. | 06 Jun 2025 | |||
| FMR LLC | 4.1% | $146,139,596 | 2,885,853 | FMR LLC | 31 Dec 2025 | |||
| Sofinnova Venture Partners X, L.P. | 4% | $128,465,927 | 2,847,837 | Dr. Maha Katabi ("Katabi") | 10 Dec 2025 | |||
| Point72 Asset Management, L.P. | 1.7% | $51,344,964 | 1,229,525 | Point72 Asset Management, L.P. | 25 Mar 2026 |
As of 30 Jun 2026, 218 institutional investors reported holding 77,932,315 shares of Vera Therapeutics, Inc. - Class A common stock, $0.001 par value per share (VERA). This represents 109% of the company’s total 71,530,793 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
86%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 8% | 5,747,760 | +13% | 0% | $246,636,382 |
| Avoro Capital Advisors LLC | 8% | 5,723,888 | -2.8% | 2.2% | $245,612,034 |
| STATE STREET CORP | 5.8% | 4,148,786 | +23% | 0.01% | $178,024,407 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.6% | 4,012,936 | -12% | 0.02% | $172,196,000 |
| Deep Track Capital, LP | 5.6% | 4,000,000 | -2.6% | 2.5% | $171,640,000 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 5.5% | 3,916,400 | +5.2% | 1.8% | $168,052,724 |
| Kynam Capital Management, LP | 4% | 2,890,059 | -15% | 6.9% | $124,012,432 |
| MORGAN STANLEY | 3.9% | 2,799,459 | +659% | 0.01% | $120,124,806 |
| Sofinnova Investments, Inc. | 3.9% | 2,793,987 | 0% | 6.4% | $119,889,982 |
| FMR LLC | 3.9% | 2,774,070 | +3.6% | 0.01% | $119,035,323 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 2,755,413 | +2.7% | 0% | $118,234,772 |
| Eversept Partners, LP | 3.1% | 2,212,770 | +1.8% | 5.2% | $94,949,961 |
| Logos Global Management LP | 3.1% | 2,200,000 | 4.1% | $94,402,000 | |
| Integral Health Asset Management, LLC | 2.4% | 1,750,000 | +9.4% | 3.1% | $75,092,500 |
| Bellevue Group AG | 2.4% | 1,710,808 | +0% | 1.5% | $73,410,771 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 1,692,442 | +7.8% | 0% | $72,637,914 |
| ALLIANCEBERNSTEIN L.P. | 2.2% | 1,591,043 | +21% | 0.02% | $64,007,660 |
| GOLDMAN SACHS GROUP INC | 1.9% | 1,380,835 | +22% | 0.01% | $59,251,630 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1.8% | 1,295,405 | +135% | 0.52% | $55,585,829 |
| Pictet Asset Management Holding SA | 1.7% | 1,249,414 | +19% | 0.05% | $53,625,486 |
| DEUTSCHE BANK AG\ | 1.5% | 1,102,106 | +107% | 0.01% | $47,291,369 |
| Qube Research & Technologies Ltd | 1.5% | 1,083,179 | +100% | 0.05% | $46,479,211 |
| Woodline Partners LP | 1.4% | 1,001,037 | 0% | 0.13% | $42,954,498 |
| AMERICAN CENTURY COMPANIES INC | 1.2% | 866,243 | +19% | 0.02% | $37,170,604 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.9% | 642,873 | +16% | 0% | $27,585,680 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Latest
Q2 2026
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 77,932,315 | $3,340,046,613 | +$264,642,531 | $42.91 | 218 |
| 2026 Q1 | 72,234,409 | $2,918,504,604 | -$101,315,750 | $40.23 | 227 |
| 2025 Q4 | 74,007,592 | $3,747,901,676 | +$504,714,925 | $50.64 | 214 |
| 2025 Q3 | 65,067,827 | $1,890,768,857 | +$37,111,876 | $29.06 | 173 |
| 2025 Q2 | 63,893,006 | $1,505,324,602 | +$17,298,219 | $23.56 | 171 |
| 2025 Q1 | 62,915,975 | $1,512,522,250 | -$90,036,678 | $24.02 | 176 |
| 2024 Q4 | 62,912,622 | $2,660,465,176 | +$389,856,746 | $42.29 | 177 |
| 2024 Q3 | 53,519,938 | $2,365,061,400 | -$1,769,076 | $44.20 | 172 |
| 2024 Q2 | 52,988,211 | $1,917,110,562 | +$57,678,654 | $36.18 | 169 |
| 2024 Q1 | 51,298,718 | $2,212,007,022 | +$474,171,827 | $43.12 | 157 |
| 2023 Q4 | 41,345,437 | $635,880,813 | +$44,778,975 | $15.38 | 93 |
| 2023 Q3 | 39,258,779 | $538,195,352 | +$9,620,413 | $13.71 | 84 |
| 2023 Q2 | 38,127,621 | $611,912,465 | +$42,587,635 | $16.05 | 76 |
| 2023 Q1 | 37,354,429 | $289,749,836 | +$137,641,985 | $7.76 | 69 |
| 2022 Q4 | 21,331,464 | $412,748,829 | -$7,253,468 | $19.35 | 57 |
| 2022 Q3 | 21,539,667 | $459,015,997 | +$19,117,341 | $21.31 | 55 |
| 2022 Q2 | 20,391,008 | $277,615,038 | +$7,846,841 | $13.61 | 49 |
| 2022 Q1 | 19,483,745 | $457,319,068 | +$130,146,246 | $23.49 | 49 |
| 2021 Q4 | 14,054,730 | $374,899,000 | +$10,499,638 | $26.72 | 37 |
| 2021 Q3 | 14,710,587 | $252,433,000 | +$4,174,540 | $17.35 | 30 |
| 2021 Q2 | 14,513,290 | $186,104,000 | +$186,104,000 | $13.25 | 21 |